DePuy Synthes’ Teligen System Cleared

Johnson & Johnson subsidiary DePuy Synthes has received FDA clearance for its Teligen system for minimally invasive surgical transforaminal lumbar interbody fusion (TLIF) procedures using digital visualization.

The system is comprised of a tower that includes a camera control system, a procedure kit with a disposable high-definition camera, a discectomy device and disposable ports.

TLIF is a common posterior surgical approach for spinal fusion to address low back pain caused by degenerative disease or spinal instability. Open TLIF can present clinical challenges, including greater soft tissue disruption, increased risk of complications, slower recovery and variable long-term outcomes, such as greater back pain and disability, the company said.

DePuy Synthes expects to launch the system in the U.S. later this year.